Artiva Biotherapeutics, Inc. ARTV Q1 2025 earnings
Reported May 8, 2025 · Before market open
EPS estimate-$0.68
Next report
Aug 5, 2026 (in a month)EPS estimate-$0.64
Financials
Q1 2025Valuation & ratios
Versus estimates
Diluted EPS
Ask the moment Artiva Biotherapeutics, Inc. reports.
Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.
Connect your AI
Claude
Questions, answered.
- When did Artiva Biotherapeutics, Inc. report Q1 2025 earnings?
- Artiva Biotherapeutics, Inc. (ARTV) reported Q1 2025 earnings on May 8, 2025 before market open.
- What were Artiva Biotherapeutics, Inc.'s Q1 2025 revenue and EPS?
- Artiva Biotherapeutics, Inc. reported revenue of - and diluted EPS of $-0.83 for Q1 2025.
- Did Artiva Biotherapeutics, Inc. beat estimates in Q1 2025?
- EPS missed the consensus estimate of $-0.68 by $0.15.
- How did Artiva Biotherapeutics, Inc.'s Q1 2025 results compare year-over-year?
- Compared to the same quarter a year prior, revenue declined 100.0% from $251.0K a year earlier and diluted EPS grew 96.2% from $-22.00.
- Where can I find Artiva Biotherapeutics, Inc.'s Q1 2025 SEC filings?
- You can read the 10-Q periodic report (0000950170-25-066421) directly on SEC EDGAR. The filing index links above go to sec.gov.